IDEAYA Biosciences (IDYA) Stock Price, Quote, News & History | Benzinga

IDEAYA Biosciences Inc (IDYA) Stock Price, Quote, News & History

IDYANASDAQ

Trade with Public

Trade with Public

$37.02

0.782.15%

At close: Aug 7, 5:00 PM EST

$37.02

N/A

After Hours: 4:00 PM EST

Earnings: Q2 2026 Earnings were released on Tue Aug 4th, before the market open

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$36.50

Close

$37.02

Volume / Avg.

602.34K / 1.10M

Day Range

$36.27 - $37.03

52 Wk Range

22.09 - 40.58

Market Cap

$3.56B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

11.55%

Days to Cover

8.61

Recent IDEAYA Biosciences, Inc. News

Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Biosciences, Perrigo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures higher, Nasdaq up 200 points. Mission Produce (NASDAQ: AVO) shares down on weak earnings. Other stocks also down in pre-market.

Avi Kapoor

Why Nuvalent Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT, MTEN, NCRA, ZTG, EPSM, DBI, APLD. Losers include BYAH, NOTV.

Avi Kapoor

Leggett & Platt, Allogene Therapeutics, Revolution Medicines And Other Big Stocks Moving Higher On Monday

U.S. stocks were mixed on Monday, with the Dow Jones falling over 200 points. Leggett & Platt rose on news of being acquired by Somnigroup.

Avi Kapoor

IDEAYA Eye Cancer Trial Data Beats Standard Therapy, Stock Soars

IDEAYA shares rise after darovasertib trial shows progression-free survival benefit in uveal melanoma; NDA filing planned for 2026.

Vandana Singh

Stock Market Today: Dow Futures Fall As Trump Announces Strait Of Hormuz Blockade—Goldman Sachs, Fastenal In Focus (UPDATED)

Editor’s note: The future prices of benchmark tracking ETFs and pre-market prices of stocks have been updated. U.S. stock futures declined on Monday following Friday's mixed close. Futures of major benchmark indices were lower after President Donald Trump announced a blockade of the Strait of Hormuz.

Benzinga Neuro

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-111.66M

Investing Cash Flow (TTM)

-92.74M

Financing Cash Flow (TTM)

362.82M

Free Cash Flow (TTM)

-113.87M

Capital Expenditure (TTM)

-2.21M

Net Change in Cash (TTM)

158.42M

Analyst Trends and Forecast

4

1

Apr

1

May

2

Jun

2

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.69B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

13.85

PB Ratio (TTM)

2.91

Earnings Yield % (TTM)

-5.30%

Earnings Yield % (FWD)

-13.69%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$12.45

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$272.59M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$36.50

Close

$37.02

Volume / Avg.

602.34K / 1.10M

Day Range

$36.27 - $37.03

52 Wk Range

22.09 - 40.58

Market Cap

$3.56B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

11.55%

Days to Cover

8.61

About

Sector

Health Care

Industry

Biotechnology

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug dis...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy IDEAYA Biosciences (IDYA) stock?

A

You can purchase shares of IDEAYA Biosciences (NASDAQ:IDYA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are IDEAYA Biosciences (IDYA) competitors?

A

There are no as such competitors for IDEAYA Biosciences.

Q

What is the forecast, or price target, for IDEAYA Biosciences (IDYA) stock?

A

IDEAYA Biosciences has a consensus price target of $52.15.

Q

What is the current price for IDEAYA Biosciences (IDYA)?

A

The stock price for IDEAYA Biosciences (NASDAQ: IDYA) is $37.02 last updated August 7, 2026 at 4:00 PM EDT.

Q

Does IDEAYA Biosciences (IDYA) pay a dividend?

A

There are no upcoming dividends for IDEAYA Biosciences.

Q

When is IDEAYA Biosciences (NASDAQ:IDYA) reporting earnings?

A

IDEAYA Biosciences does not have any upcoming earnings scheduled.

Q

Is IDEAYA Biosciences (IDYA) going to split?

A

There is no upcoming split for IDEAYA Biosciences.

Q

What sector and industry does IDEAYA Biosciences (IDYA) operate in?

A

IDEAYA Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.